Alterations of β-adrenoceptors subsequent to myocardial infarction

  • P. Dominiak
  • D. Türck
Conference paper


Elevations and reductions of the number of β-adrenoceptor binding sites are dependent on the strength and the duration of receptor interaction with respective agonists. — In the paper presented here, results obtained by the authors concerning biosynthesis, storage and release of catecholamines following experimentally induced infarction of the myocardium in rats are compared with those of other authors for other species.

Principally, storage and release of noradrenaline from ischemic hearts do not differ with the mode of inducing tissue hypoxia (stopped-flow ischemia, coronary artery ligation, occlusion of the great cardiac vein), nor for various species (rat, dog, guinea-pig).

Differences are, however, present in the results of several β-adrenoceptor binding studies performed after experimental myocardial infarction. Following acute infarction, an increase in the number of β-adrenoceptor binding sites is generally observed, which is explained on the basis of an externalization of receptors from the cytoplasm of the sarcolemmal membrane. Results pertaining to 2–3 days after infarction are not uniform: in guinea-pig hearts a marked drop in the number of β-adrenoceptors has been reported, a mild rise in the number has been detected in the left and right ventricle of rat hearts.

These divergent observations could arise from the experimental protocol employed, for instance in the binding assay and in the pretreatment given to the hearts prior to assay.

Key words

myocardial infarction changes in β-adrenoceptor binding sites catecholamines translocation of β-adrenoceptors 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Baumann G, Riess G, Erhardt WD, Felix SB, Ludwig L, Blümel G, Blömer H (1981) Impaired beta-adrenergic stimulation in the uninvolved ventricle post-acute myocardial infarction: reversible defect due to excessive circulating catecholamine-induced decline in number and affinity of beta-receptors. Am Heart J 101: 569–581PubMedCrossRefGoogle Scholar
  2. 2.
    Benfey BG, Elfellah MS, Ogilvie RI, Varma DR (1984) Anti-arrhythmic effects of prazosin and propranplol during coronary artery occlusion and re-perfusion in dogs and pigs. Br J Pharmacol 82: 717–725PubMedCrossRefGoogle Scholar
  3. 3.
    Brodde OE, Prywarra A, Daul A, Anlauf M, Bock KD (1984) Correlation between lymphocyte beta2-adrenoceptor density and mean arterial blood pressure: elevated beta-adrenoceptors in essential hypertension. J Cardiovasc Pharmacol 6: 678–682PubMedCrossRefGoogle Scholar
  4. 4.
    Chuang de-M, Costa E (1979) Evidence for internalization of the recognition site of ß-adrenergic receptors during receptor subsensitivity induced by (—)-isoproterenol. Proc Natl Acad Sci USA 76: 3024–3028PubMedCrossRefGoogle Scholar
  5. 5.
    DaPrada M, Zürcher G (1976) Simultaneous radioenzymatic determination of plasma and tissue adrenaline, noradrenaline and dopamine within the femtomole range. Life Sci 19: 1161–1174CrossRefGoogle Scholar
  6. 6.
    Dominiak P, Grobecker H (1982) Elevated plasma catecholamines in young hypertensive and hyperkinetic patients: effect of pindolol. Br J Clin Pharmacol 13: 381S - 390SPubMedCrossRefGoogle Scholar
  7. 7.
    Dominiak P, Schulz W, Delius W, Kober G, Grobecker H (1981) Catecholamines in patients with coronary heart disease. In: Delius W, Gerlach E, Grobecker H, Kübler W (eds), Catecholamines and the heart. Springer-Verlag, Berlin Heidelberg New York, pp 223–235CrossRefGoogle Scholar
  8. 8.
    Dominiak P, Delius W, Grobecker H (1985) Changes in plasma catecholamine concentrations in patients with coronary heart disease during pacing and physical exercise. Clin Cardiol 8: 77–81PubMedCrossRefGoogle Scholar
  9. 9.
    Kissinger PT, Brüntlett CS, Shoup RE (1981) Neurochemical applications of liquid chromatography with electrochemical detection. Life Sci 28: 455–465PubMedCrossRefGoogle Scholar
  10. 10.
    Limas CJ, Limas C (1984) Rapid recovery of cardiac ß-adrenergic receptors after isoproterenolinduced “down”-regulation. Circ Res 55: 524–531PubMedCrossRefGoogle Scholar
  11. 11.
    Maisel AS, Motulsky HJ, Insel PA (1985) Externalization of ß-adrenergic receptors promoted by myocardial ischemia. Science 230: 183–186PubMedCrossRefGoogle Scholar
  12. 12.
    Mukherjee A, Wong TM, Buja LM, Lefkowitz RJ, Willerson JT (1979) Beta adrenergic and muscarinic cholinergic receptors in canine myocardium. J Clin Invest 64: 1423–1428PubMedCrossRefGoogle Scholar
  13. 13.
    Mukherjee A, Bush LR, McCoy KE, Duke RJ, Hagler H, Buja LM, Willerson JT (1982) Relationship between β-adrenergic receptor numbers and physiological responses during experimental canine myocardial ischemia. Circ Res 50: 735–741PubMedCrossRefGoogle Scholar
  14. 14.
    Nadeau RA, deChamplain J (1979) Plasma catecholamines in acute myocardial infarction. Am Heart J 98: 548–554PubMedCrossRefGoogle Scholar
  15. 15.
    Nagatsu T, Oka K, Kato T (1979) Highly sensitive assay for tyrosine hydroxylase activity by high-performance liquid chromatography. J Chromatogr 163: 247–252PubMedCrossRefGoogle Scholar
  16. 16.
    O’Malley K, O’Brien E, Fitzgerald D, Kelly J (1985) Adrenoceptors and hypertension. In: Szabadi E, Bradshaw CM, Nahorski SR (eds), Pharmacology of adrenoceptors. VCH-Publishers, Weinheim, pp 197–204Google Scholar
  17. 17.
    Peuler JD, Johnson GA (1977) Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamine. Life Sci 21: 625–636PubMedCrossRefGoogle Scholar
  18. 18.
    Schömig A, Dart AM, Dietz R, Mayer E, Kübler W (1984) Release of endogenous catecholamines in the ischemic myocardium of the rat. Part A: locally mediated release. Circ Res 55: 689–701PubMedCrossRefGoogle Scholar
  19. 19.
    Sibley DR, Lefkowitz RJ (1985) Molecular mechanisms of receptor desensitization using the ß-adrenergic receptor-coupled adenylate cyclase system as a model. Nature 317: 124–129PubMedCrossRefGoogle Scholar
  20. 20.
    Stiles GL, Caron MG, Lefkowitz RJ (1984) ß-adrenergic receptors: biochemical mechanisms of physiological regulation. Physiol Rev 64: 661–743PubMedGoogle Scholar
  21. 21.
    Takeda N, Dominiak P, Türck D, Rupp H, Jacob R (1985) The influence of endurance-training on mechanical catecholamine responsiveness, β-adrenoceptor density and myosine isoenzyme pattern of rat ventricular myocardium. Basic Res Cardiol 80: 88–99PubMedCrossRefGoogle Scholar
  22. 22.
    Takeda N, Dominiak P, Türck D, Rupp H, Jacob R (1985) Myocardial catecholamine responsiveness of spontaneously hypertensive rats as influenced by swimming training. Basic Res Cardiol 80: 384–391PubMedCrossRefGoogle Scholar
  23. 23.
    Williams RS, Lefkowitz RI (1978) Alpha-adrenergic receptors in rat myocardium. Identification by binding of 3H-dihydroergocryptine. Circ Res 43: 721–727PubMedCrossRefGoogle Scholar
  24. 24.
    Zimmer H-G, Gerlach E (1980) Early metabolic alterations during the development of experimentally induced cardiac hypertrophy. Drug Res 30: 2001–2007Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1986

Authors and Affiliations

  • P. Dominiak
    • 1
  • D. Türck
    • 2
  1. 1.Physiologisches InstitutUniversität MünchenMunich 2Germany
  2. 2.Physiologisches InstitutUniversität MünchenGermany

Personalised recommendations